BlackRock Updates Boston Scientific Stake in SC 13G/A Filing

Ticker: BSX · Form: SC 13G/A · Filed: 2024-01-25T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investment

TL;DR

**BlackRock just updated its Boston Scientific holdings, signaling continued institutional interest.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Boston Scientific Corp. common stock as of December 31, 2023. This filing, Amendment No. 12, updates their previous disclosures regarding their investment in the medical device company. For investors, this matters because BlackRock is a major institutional investor, and changes in their reported holdings can signal shifts in their investment strategy or outlook on Boston Scientific's future performance.

Why It Matters

This filing shows BlackRock's continued significant institutional ownership in Boston Scientific, which can influence market perception and stock stability. Large institutional holdings often suggest confidence in a company's long-term prospects.

Risk Assessment

Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate significant risk or opportunity.

Analyst Insight

Investors should note BlackRock's continued presence as a major shareholder, which can be a sign of stability, but should also monitor future filings for any significant changes in their reported ownership percentage.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this and what does it generally indicate?

This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It indicates that a passive institutional investor, in this case BlackRock Inc., is updating its ownership stake in a public company, Boston Scientific Corp., as of a specific date, December 31, 2023.

Who is the reporting person in this filing?

The reporting person is BlackRock Inc., a large institutional asset manager with a Central Index Key (CIK) of 0001364742, located at 50 Hudson Yards, New York, NY.

Which company's securities are being reported on?

The securities being reported on belong to BOSTON SCIENTIFIC CORP, identified by CIK 0000885725 and CUSIP number 101137107, with its business address at 300 Boston Scientific Way, Marlborough, MA.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, meaning the reported ownership reflects BlackRock's holdings as of the end of last year.

What is the significance of 'Amendment No: 12'?

The 'Amendment No: 12' indicates that this is the twelfth update or revision BlackRock Inc. has made to its Schedule 13G filing regarding its ownership in Boston Scientific Corp., suggesting a history of significant and ongoing investment in the company.

From the Filing

0001086364-24-003245.txt : 20240125 0001086364-24-003245.hdr.sgml : 20240125 20240125134851 ACCESSION NUMBER: 0001086364-24-003245 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43484 FILM NUMBER: 24561022 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us1011371077_012524.txt us1011371077_012524.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 12) BOSTON SCIENTIFIC CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 101137107 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 101137107 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 113711842 (6) Shared voting power 0 (7) Sole dispositive power 127036665 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 127036665 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 8.7% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- BOSTON SCIENTIFIC CORP Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or

View on Read The Filing